gerald phd mcmahon  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors gerald phd mcmahon check out list of companies and businesses related to gerald phd mcmahon find out gerald phd mcmahon address and contact details view other people related to gerald phd mcmahon  coworkers colleagues companions etc address  elliott ave west suite  seattle  wa companies related to gerald phd mcmahon cikcompany namepositioncompany addresscelldex therapeutics incdirector  frontage road suite  hampton poniard pharmaceuticals incchief executive officer  elliott avenue west suite  seattle mateon therapeutics incdirector  gateway blvd suite  south san francisco  gerald phd mcmahon on the web persons related to gerald phd mcmahon  celldex therapeutics incnamepositioncitymarucci anthonyhamptoncatlin averyhamptonkeith l brownliedirector tarrytownfrancis r canodirector los altosavery w catlinsr vp  cfo hinghamavery w catlinsr vp  cfo needhamavery w catlinsr vp  cfo hamptonsarah cavanaughsvp of corp affairs  admin hamptonherbert j conraddirector middletonherbert j conraddirector glen rockherbert j conraddirector needhamherbert j conraddirector hamptonmichael timothy cooke new yorkelizabeth crowleysr vp cpdo hamptonthomas andrew davisexecutive vp  cmo gaithersburgthomas andrew davisclarksvillethomas andrew davissr vp  cmo clarksvillethomas andrew davissr vp  cmo needhamthomas andrew davissr vp  cmo hamptonlarry ellbergerdirector upper saddle riverlarry ellbergerdirector livingstonlarry ellbergerdirector needhamlarry ellbergerdirector hamptonronald w ellissr vp rd newtongeorge elstondirector chathamgeorge elstondirector needhamgeorge elstondirector hamptonpaula r freeman worcestermichael e furlongsr dir bus development wilmingtonelston georgehamptonpenner jr harryhamptonconrad herberthamptonshoos karenhamptontaha keilani cantontibor kelerexecutive vp  cso ottsvilletibor kelersr vp  cso needhamtibor kelersr vp  cso hamptonfrederick w kyledirector philadelphiaellberger larryhamptontheresa lavalleesvp reg precision medicine hamptonalf a lindbergdirector se  stockholmalf a lindbergdirector londonkaren shoos liptondirector bethesdakaren shoos liptondirector needhamkaren shoos liptondirector hamptonlorantis holdings ltd owner cambridgejames j marinodirector princetonhenry c marsh jrvp research readingsamuel bates martinhamptonanthony s maruccipresident  ceo mendhamanthony s maruccipresident  ceo needhamanthony s maruccipresident  ceo hamptongerald phd mcmahondirector seattlemedarex inc owner princetonronald c newboldsr vp business dev martinsvillemary nicholson westonthomas s palucksummitrajesh r parekhdirector needhamrajesh r parekhdirector needhampdi incdirector livingstonharry penner jrdirector guilfordharry penner jrdirector needhamharry penner jrdirector hamptonronald pepinsr vp  cbo princetonronald pepinsr vp  cbo needhamronald pepinsr vp  cbo hamptonvan den broek richardhamptonuna s ryanpresident  ceo chestnut hillcharles r schallerdirector okatiecharles r schallerdirector needhampeter a searsdirector west chestertimothy m shannonneedhamtimothy m shannondirector needhamtimothy m shannondirector hamtponshannon m d timothyhamptonden broek richard vandirector newarkden broek richard vangreenwichj barrie warddirector needhamrichard m wrightsr vp  cco hamptonpersons related to gerald phd mcmahon  poniard pharmaceuticals incnamepositioncityrobert s bassodirector so san franciscorobert s bassodirector san franciscobay city capital fund i l p owner san franciscobay city capital fund iv co invesment fund lpsan franciscobay city capital fund iv co invesment fund lpsan franciscobay city capital fund iv lpsan franciscobay city capital fund iv lpsan franciscobay city capital llc owner san franciscobay city capital llc owner san franciscobay city capital management iv llcsan franciscobay city capital management iv llcsan franciscobay city capital management llc owner san franciscosusan d berlandcfo seattlefred b cravesdirector san franciscofred b cravesdirector san franciscofred b cravesdirector san franciscojager robert dechief medical officer south san franciscoe rolland dicksondirector rochestere rolland dicksondirector mantorvillelinda t findlayvp human resources seattleansbert gadickebostonnicholas galakatosbostonalan b md glassbergchief medical officer seatlecarl goldfischerdirector san franciscocarl goldfischerdirector san franciscocarl goldfischerdirector san franciscokaren auditore hargreaveschief operating officer seattledennis hennerbostonmichael k jacksonprincipal accounting officer seattlemichael k jacksoninterim cfo seattledavid a karlinsr vp clinical devlpt  reg seattledavid a karlinsr vp clinical devlpt  reg so san franciscocheni kwokvp bus devlpt seattlecheni kwokvp bus devlpt so san franciscorobert k littauerdirector seattlerobert k littauerdirector seattlecaroline m loewyevp planning  ir seattlecaroline m loewycfo so san franciscogary a lyonsdirector san franciscogary a lyonsdirector s san franciscoron martelldirector seattleron martellchief executive officer so san franciscoron martellchief executive officer san franciscogerald phd mcmahonchief executive officer seattlegerald phd mcmahondirector so san franciscogerald phd mcmahondirector san franciscompm asset management investors  bviii llcbostonmpm bioventures iii gmbh  co beteiligungs kgbostonmpm bioventures iii gp lpbostonmpm bioventures iii llc owner bostonmpm bioventures iii lpbostonmpm bioventures iii parallel fund lpbostonmpm bioventures iii qp lpbostonmichael s perrypresident  cmo s san franciscomichael s perrypresident  cmo san franciscomichael s perrypresident  cmo seattlenicholas j simon iiidirector bostonalan a steigroddirector newport beachmichael steinmetzbostondavid r stevensdirector seattledavid r stevensdirector seattlegregory l weaverchief financial officer south san franciscokurt wheelerbostonanna l wightvp legal seattleanna l wightvp legal so san franciscopersons related to gerald phd mcmahon  mateon therapeutics incnamepositioncitywood alastairsouth san franciscodavid chaplinchief scientific officer walthamdavid chaplinchief scientific officer south san franciscodavid chaplindirector south san franciscodavid chaplinpresident and ceo south san franciscorichard chinpresident and ceo walthamrichard chinpresident and ceo walthamjoel tomas citrondirector walthamchaplin davidsouth san franciscofrederick w driscolldirector walthamfrederick w driscolldirector south san franciscogerald a eppnerroy h ficklingdirector walthamroy h ficklingdirector south san franciscoroy h ficklingdirector south san franciscopamela hasouth san franciscopeter harrischief medical officer walthamtamar d howsondirector princetontamar d howsondirector south san franciscotamar d howsonsouth san franciscomurphy jamessouth san franciscodavid louis johnsonsouth san franciscomark kesselwalthammark kesseldirector south san franciscomark kesseldirector south san franciscojohn a kollinschief executive officer walthamarthur b lafferdirector walthamarthur b lafferdirector south san franciscopeter langeckerchief executive officer south san franciscosten lindahlwalthammatthew m loarchief financial officer kessel marksouth san franciscogerald phd mcmahondirector seattlegerald phd mcmahondirector south san franciscogerald phd mcmahondirector south san franciscojames b murphychief financial officer walthamjames b murphychief financial officer south san franciscosimon pedderdirector charlottelangecker petersouth san franciscodonald rogers reynoldsdirector south san franciscobarbara richingchief financial officer fremontbarbara richingchief financial officer south san franciscofickling roysouth san franciscobobby w phd sandagedirector lexingtonwilliam d schwietermanpresident and ceo walthamwilliam d schwietermandirector south san franciscowilliam d schwietermandirector south san franciscowilliam n shieblerdirector walthamwilliam n shieblerdirector south san franciscowilliam n shieblerdirector south san franciscowilliam n shieblerdirector south san franciscoper olof soderbergdirector walthamsymphony capital gp lpnew yorksymphony capital partners lpdirector new yorksymphony gp llcnew yorksymphony vida holdings llcnew yorkharri v tarantonew yorkpatricia a walickevp and chief medical officer walthamschwieterman williamsouth san franciscoshiebler williamsouth san franciscoalastair jj woodwalthamalastair jj wooddirector south san franciscoalastair jj wooddirector south san franciscoscott youngchief operating officer walthamrichard zecherdirector waltham form  celldex therapeutics for apr  filed by mcmahon gerald phd research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  celldex therapeutics for apr  filed by mcmahon gerald phd by k wizard—  pm et  httparchivefastedgarcomaczzczakqwztswlzzrz filed on april   more cldx news celldex provides corporate update and reports full year  results globenewswire   pm et  celldex therapeutics announces appointment to board of directors globenewswire   pm et  celldex therapeutics announces upcoming investor presentations and  yearend call globenewswire   pm et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top bofi log in for events hafc an earn epam sn log in for events chkp lho fit gts find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  cldx stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventscldx celldex therapeutics inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all briefcelldex therapeutics promotes sam martin as cfo reuters –  am et  celldex therapeutics inc cldx  celldex therapeutics cldx announces additions to the board of directors and senior management team  celldex therapeutics inc cldx  sam martin has been promoted to senior vice president and chief financial officer effective july   celldex therapeutics announces additions to the board of directors and senior management team globenewswire –  am et  celldex therapeutics inc cldx today announced additions to the board of directors and senior management team keith brings an exceptional background in finance and accounting within the life sciences industry said larry ellberger chairman of the board of directors at celldex therapeutics celldex therapeutics to participate in the jefferies  global healthcare conference globenewswire –  pm et  celldex therapeutics inc cldx announced today that tibor keler phd cofounder executive vice president and chief scientific officer and thomas davis md executive vice president and chief medical officer will participate in a fireside chat at the jefferies  global healthcare conference on june   at  am edt in new york celldex therapeutics presents phase  study of varlilumab and opdivo® at  asco annual meeting globenewswire –  pm et  celldex therapeutics inc cldx announced today data from the phase  portion of a phase  dose escalation and cohort expansion study examining the combination of varlilumab celldexs cd targeting investigational immuneactivating antibody and bristolmyers squibbs antipd immunotherapy opdivo® rachel e sanborn md codirector of the providence thoracic oncology program and phase i c briefcelldex presents data from phase  study of glembatumumab vedotin reuters –  am et  celldex therapeutics inc cldx  celldex presents promising overall survival data from phase  study of singleagent glembatumumab vedotin in patients with checkpointrefractory metastatic melanoma  safety profile was consistent with prior studies of glembatumumab vedotin​ source text for eikon further company coverage celldex presents promising overall survival data from phase  study of singleagent glembatumumab vedotin in patients with checkpointrefractory metastatic melanoma globenewswire –  am et  celldex therapeutics inc cldx today presented positive mature results from the companys phase  study of glembatumumab vedotin in patients with stage iiiiv checkpoint inhibitorrefractory and if applicable brafmek inhibitorrefractory metastatic melanoma george o elston named chief executive officer of x oncology globenewswire –  pm et  x oncology inc a company focused on developing targeted therapeutics to address significant unmet needs in womens cancer announces that its board of directors has appointed veteran life science executive george o elston as its chief executive officer celldex therapeutics to present clinical results at  asco annual meeting globenewswire –  pm et  celldex therapeutics inc cldx announced today that clinical results from the singleagent cohort of the phase  study of glembatumumab vedotin in patients with metastatic melanoma and the phase  doseescalation study of varlilumab and nivolumab in multiple solid tumors will be presented in oral presentations at the  american society of clinical oncology annual meeting being held june   biotech stocks under scanner  biocryst pharma biogen celldex therapeutics and concordia pr newswire –  am et  new york may   on monday may   the nasdaq composite ended the trading session at  up  the dow jones industrial average edged  higher to finish at  and the sp  closed at  marginally advancing  gains were broad based as all the nine sectors ended the day in positive httpstockcallerscomregistration biocryst pharma   on mond briefcelldex reports q loss per share  reuters –  pm et  celldex therapeutics inc cldx  celldex reports first quarter  results  q loss per share   q revenue  million versus  million  q revenue view   thomson reuters ibes  q earnings per share view   thomson reuters ibes source text for eikon further company coverage celldex reports first quarter  results globenewswire –  pm et  celldex therapeutics inc cldx today reported business and financial highlights for the first quarter ended march   in the first quarter of  celldex made considerable progress across our pipeline said anthony marucci cofounder president and chief executive officer of celldex therapeutics celldex provides corporate update and reports full year  results globenewswire –  pm et  celldex therapeutics inc cldx today reported business and financial highlights for the fourth quarter and yearended december   celldex therapeutics announces appointment to board of directors globenewswire –  pm et  celldex therapeutics inc cldx today announced the appointment of james j marino jd to the companys board of directors jims wealth of experience advising numerous life science companies provides us additional perspective on the current healthcare business environment said larry ellberger chairman of the board of directors at celldex therapeutics celldex therapeutics announces upcoming investor presentations and  yearend call globenewswire –  pm et  celldex therapeutics inc cldx announced today upcoming investor events for february and march page page  todays and upcoming events aug  cldx to announce q earnings after market confirmed aug  cldx earnings conference call at  pm listen past events last  days jun  shareholders meeting data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe gerald mcmahon phd  people and organizations at ysm  yale school of medicine share tweet email print decrease font size reset font size increase font size gerald mcmahon phd departments  organizations medical oncology education  training phd rensselaer polytechnic institute  edit this profile contact info gerald mcmahon phd close close modal title close how will my information be used when you express interest in a specific study the information from your profile will be sent to the doctor conducting that study if youre eligible to participate you may be contacted by a nurse or study coordinator if you select a health category rather than a specific study doctors who have active studies in that area may contact you to ask if you would like to participate in both cases you will be contacted by the preferred method email or phone that you specified in your profile mcmahon gerald phd insider insider trades  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  quotes  ownership  insider trades  individual insiders insider trades of mcmahon gerald phd click on the column header to resort ascending ▲ or descending ▼ individual insider trades company relation last date ▼ type tran ownertype shares traded last price shares held celldex therapeutics inc director  form  disposition non open market direct    celldex therapeutics inc director  form  acquisition non open market direct    celldex therapeutics inc director  form  disposition non open market direct    celldex therapeutics inc director  form  disposition non open market direct    celldex therapeutics inc director  form  disposition non open market direct    celldex therapeutics inc director  form  disposition non open market direct    highest rated articles of last week merck and pfizer collaborate with corning to modernize  chipotle the bull case for queso lockheed martin invests in contextere to transform the future of work petiq inc nasdaq petq to ring the nasdaq stock market opening morgan stanley chooses frankfurt as eu hub post brexit  source view all highest rated most rated stocks of last week rated stocks for nasdaq nyse and amex symbol  ratings consensus aapl  bullish of  ratings rate it fb  bullish of  ratings rate it nflx  bullish of  ratings rate it amd  bullish of  ratings rate it nvda  bullish of  ratings rate it f  bullish of  ratings rate it twtr  bullish of  ratings rate it goog  bullish of  ratings rate it jpm  bullish of  ratings rate it ba  bullish of  ratings rate it more most rated stocks closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex gerald mcmahon phd  web design showcase  communications  web group  yale school of medicine share tweet email print decrease font size reset font size increase font size gerald mcmahon phd departments  organizations medical oncology education  training phd rensselaer polytechnic institute  edit this profile contact info gerald mcmahon phd close close modal title close how will my information be used when you express interest in a specific study the information from your profile will be sent to the doctor conducting that study if youre eligible to participate you may be contacted by a nurse or study coordinator if you select a health category rather than a specific study doctors who have active studies in that area may contact you to ask if you would like to participate in both cases you will be contacted by the preferred method email or phone that you specified in your profile form  celldex therapeutics for may  filed by mcmahon gerald phd research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  celldex therapeutics for may  filed by mcmahon gerald phd by k wizard—  pm et  httparchivefastedgarcomaczuczuwzeslzzrz filed on may   more cldx news celldex provides corporate update and reports full year  results globenewswire   pm et  celldex therapeutics announces appointment to board of directors globenewswire   pm et  celldex therapeutics announces upcoming investor presentations and  yearend call globenewswire   pm et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top bofi log in for events hafc an earn epam sn log in for events chkp lho fit gts find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  cldx stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventscldx celldex therapeutics inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all briefcelldex therapeutics promotes sam martin as cfo reuters –  am et  celldex therapeutics inc cldx  celldex therapeutics cldx announces additions to the board of directors and senior management team  celldex therapeutics inc cldx  sam martin has been promoted to senior vice president and chief financial officer effective july   celldex therapeutics announces additions to the board of directors and senior management team globenewswire –  am et  celldex therapeutics inc cldx today announced additions to the board of directors and senior management team keith brings an exceptional background in finance and accounting within the life sciences industry said larry ellberger chairman of the board of directors at celldex therapeutics celldex therapeutics to participate in the jefferies  global healthcare conference globenewswire –  pm et  celldex therapeutics inc cldx announced today that tibor keler phd cofounder executive vice president and chief scientific officer and thomas davis md executive vice president and chief medical officer will participate in a fireside chat at the jefferies  global healthcare conference on june   at  am edt in new york celldex therapeutics presents phase  study of varlilumab and opdivo® at  asco annual meeting globenewswire –  pm et  celldex therapeutics inc cldx announced today data from the phase  portion of a phase  dose escalation and cohort expansion study examining the combination of varlilumab celldexs cd targeting investigational immuneactivating antibody and bristolmyers squibbs antipd immunotherapy opdivo® rachel e sanborn md codirector of the providence thoracic oncology program and phase i c briefcelldex presents data from phase  study of glembatumumab vedotin reuters –  am et  celldex therapeutics inc cldx  celldex presents promising overall survival data from phase  study of singleagent glembatumumab vedotin in patients with checkpointrefractory metastatic melanoma  safety profile was consistent with prior studies of glembatumumab vedotin​ source text for eikon further company coverage celldex presents promising overall survival data from phase  study of singleagent glembatumumab vedotin in patients with checkpointrefractory metastatic melanoma globenewswire –  am et  celldex therapeutics inc cldx today presented positive mature results from the companys phase  study of glembatumumab vedotin in patients with stage iiiiv checkpoint inhibitorrefractory and if applicable brafmek inhibitorrefractory metastatic melanoma george o elston named chief executive officer of x oncology globenewswire –  pm et  x oncology inc a company focused on developing targeted therapeutics to address significant unmet needs in womens cancer announces that its board of directors has appointed veteran life science executive george o elston as its chief executive officer celldex therapeutics to present clinical results at  asco annual meeting globenewswire –  pm et  celldex therapeutics inc cldx announced today that clinical results from the singleagent cohort of the phase  study of glembatumumab vedotin in patients with metastatic melanoma and the phase  doseescalation study of varlilumab and nivolumab in multiple solid tumors will be presented in oral presentations at the  american society of clinical oncology annual meeting being held june   biotech stocks under scanner  biocryst pharma biogen celldex therapeutics and concordia pr newswire –  am et  new york may   on monday may   the nasdaq composite ended the trading session at  up  the dow jones industrial average edged  higher to finish at  and the sp  closed at  marginally advancing  gains were broad based as all the nine sectors ended the day in positive httpstockcallerscomregistration biocryst pharma   on mond briefcelldex reports q loss per share  reuters –  pm et  celldex therapeutics inc cldx  celldex reports first quarter  results  q loss per share   q revenue  million versus  million  q revenue view   thomson reuters ibes  q earnings per share view   thomson reuters ibes source text for eikon further company coverage celldex reports first quarter  results globenewswire –  pm et  celldex therapeutics inc cldx today reported business and financial highlights for the first quarter ended march   in the first quarter of  celldex made considerable progress across our pipeline said anthony marucci cofounder president and chief executive officer of celldex therapeutics celldex provides corporate update and reports full year  results globenewswire –  pm et  celldex therapeutics inc cldx today reported business and financial highlights for the fourth quarter and yearended december   celldex therapeutics announces appointment to board of directors globenewswire –  pm et  celldex therapeutics inc cldx today announced the appointment of james j marino jd to the companys board of directors jims wealth of experience advising numerous life science companies provides us additional perspective on the current healthcare business environment said larry ellberger chairman of the board of directors at celldex therapeutics celldex therapeutics announces upcoming investor presentations and  yearend call globenewswire –  pm et  celldex therapeutics inc cldx announced today upcoming investor events for february and march page page  todays and upcoming events aug  cldx to announce q earnings after market confirmed aug  cldx earnings conference call at  pm listen past events last  days jun  shareholders meeting data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe management team  harpoon therapeutics management team gerald mcmahon phd president and ceo cheleung law phd vice president translational medicine william e picht jr mba chief financial officer holger wesche phd senior vice president research gerald mcmahon phd president and chief executive officer dr mcmahon joined harpoon in december  bringing more than  years of biotechnology leadership scientific innovation and creative dealmaking experience dr mcmahon was previously president and ceo of kolltan pharmaceuticals an oncology biologics company acquired by celldex in  and senior vice president of rd oncology at medimmune the biologics arm of astrazeneca he also served as a venture partner at bay city capital and in executive leadership roles at poniard pharmaceuticals and sugen ultimately acquired by pfizer where he was a key player in the development of innovative oncology drugs sutent® and palladia®  dr mcmahon holds an academic appointment at the yale comprehensive cancer center at yale university and held previous appointments at tufts university school of medicine department of hematology  oncology at the new england medical center and the massachusetts institute of technology he received his bs in biology and phd in biochemistry from rensselaer polytechnic institute cheleung law phd vice president translational medicine dr law joined harpoon in april  with more than  years of experience in the discovery and development of novel biologics and small molecules in oncology and immunooncology dr law most recently was senior director of preclinical research at seattle genetics where he led target discovery drug technology development indenabling studies translational research and pharmacodynamic and biomarker research dr law previously held scientific positions at cdr therapeutics and xcyte therapies he was also an affiliate assistant professor in the department of microbiology at the university of washington for several years dr law received his phd in pathobiology from the university of minnesota and an mphil in biochemistry from the university of hong kong william e picht jr mba chief financial officer mr picht joined harpoon in january  with more than  years of industry experience in strategic finance operations investor relations business planning and oversight prior to harpoon he served as chief financial officer for pearl therapeutics a respiratory disease company that was sold to astrazeneca in a  billion transaction at pearl mr picht was responsible for finance administration and information technology previously he served as head of rd finance at nektar therapeutics and conducted finance and market analytics at syntex mr picht received his ba from the university of notre dame and his mba from san jose state university holger wesche phd senior vice president research dr wesche joined harpoon therapeutics with  years of biotech experience focused on target validation drug discovery and drug development as well as multisite project management in the fields of oncology and inflammation his previous role was as scientific director at amgen where he was responsible for crossfunctional organization and coordination of the next generation bite platform the industry’s leading tcell engaging antibody platform he also led several drug discovery projects through preclinical development dr wesche is coauthor of numerous publications and several us patents dr wesche received his phd summa cum laude in biochemistry and immunology from the university of hannover germany management team board of directors scientific advisory board about management team board of directors scientific advisory board technology news careers contact home about management team board of directors scientific advisory board technology news careers contact privacy policy terms of use   harpoon therapeuticsall rights reserved privacy policy terms of use website design hane chow inc   gerald mcmahon kolltan pharmaceuticals inc profile  biography  bloomberg feedback gerald mcmahon presidentceo kolltan pharmaceuticals inc career history presidentceo kolltan pharmaceuticals inc present senior vprd oncology medimmune llc unknown chairman poinard pharmaceuticals  chairmanceo poinard pharmaceuticals  chairmanpresidentceo neorx corp  chief executive officer neorx corp  president sugen inc  sugen inc  various positions sandoz pharmaceuticals corp former staff scientist tufts university school of medicine former staff scientist massachusetts institute of technology former venture partner bay city capital llc former show more website wwwkolltancom corporate information address  george street suite  new haven ct  united states phone  fax  web url wwwkolltancom from the web personal information education rensselaer polytechnic institute phd biochemistry  rensselaer polytechnic institute bachelors degree biology memberships board memberships celldex therapeutics inc board member present kolltan pharmaceuticals inc board member present mateon therapeutics inc board member  oxigene inc board member  poinard pharmaceuticals chairman  neorx corp chairman  trellis bioscience inc board member former neorx corp board member former sandoz pharmaceuticals corp board member former show more sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft gerald mcmahon phd  learn   web results aol search skip over navigation search the web web images images we found gerald mcmahon  peoplelookercom ad · wwwpeoplelookercom​gerald mcmahon  gerald mcmahons phone  address  age  more search free uncover potential relatives photos  videos historical deeds location history email address monitor social info searches related togerald mcmahon phd gerald mcmahon lawyer gerald mcmahon syracuse ny web results gerald mcmahon phd  web design showcase  communications  httpsmedicineyaleeduwebshowcasefacultygeraldmcmahonprofile gerald mcmahon phd close close modal title  gerald mcmahon phd executive profile  biography  httpswwwbloombergcomresearchstocksprivatepersonasp dr gerald mcmahon also known as jerry phd has been the chief executive officer and president at kolltan pharmaceuticals inc since april   dr mcmahon  gerald mcmahon phd  biography  traders wwwtraderscombusinessleadersgeraldmcmahonwkgebiography dr gerald mcmahon is president  chief executive officer at harpoon therapeutics inc he is on the board of directors at celldex therapeutics inc dr mcmahon was  management team  harpoon therapeutics wwwharpoontxcomaboutmanagementteam gerald mcmahon phd president and chief executive officer dr mcmahon joined harpoon in december  bringing more than  years of biotechnology leadership  dr gerald mcmahonphd  findthecompany executivesfindthecompanycomldrgeraldmcmahonphd find compensation and employment information for dr gerald mcmahonphd oxigene including salary stock awards and previous employers gerald mcmahon phd  people and organizations at ysm  httpsmedicineyaleedupeopleorganizationsgeraldmcmahonprofile when you express interest in a specific study the information from your profile will be sent to the doctor conducting that study if youre eligible to participate  harpoon therapeutics appoints gerald mcmahon phd as  wwwbusinesswirecomnewshomeenharpoon gerald mcmahon phd to lead harpoon therapeutics a company founded by mpm capital that is developing novel tcell recruiting antibody therapies fo gerald mcmahon phd for poniard pharmaceuticals inc pard wwwwikinvestcomstockponiardpharmaecuticalspardgerald gerald mcmahon phd was appointed chief executive officer of the company in may  and chairman of the board of directors in june  dr mcmahon was appointed  gerald phd mcmahon  ceo founder businessman  profile httpswwwdirectorpedianetmcmahongeraldphd check out list of companies and businesses related to gerald phd mcmahon find out gerald phd mcmahon address and contact details view other people related to gerald  gerald phd mcmahon  mateon therapeutics inc insider  httpswwwtiprankscominsidersgeraldphdmcmahon gerald phd mcmahon director at mateon therapeutics inc matn is currently unranked see this insider we found gerald mcmahon  peoplelookercom ad · wwwpeoplelookercom​gerald mcmahon  gerald mcmahons phone  address  age  more search free uncover potential relatives photos  videos historical deeds location history email address monitor social info searches related togerald mcmahon phd gerald mcmahon lawyer gerald mcmahon syracuse ny next answers gerald mcmahon gerald mcmahon born  may  is an australian fencer he competed in the individual foil event at the  summer olympics references more lynne mcmahon lynne mcmahon is an american poet she graduated from university of utah with a phd in  she teaches at university of missouri her work has more pat mcmahon actor memorable role was as gerald a wealthy spoiled boy who was ostensibly the station managers nephew by the time wallace and ladmo as it came to be more search the web  aol inc all rights reservedprivacy   terms of use   preferences   contact us   powered by bing™ wowcom  part of the aol search network background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip whats your age submit i dont know skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip